GLIDAPAFLOZIN 5 is a novel oral medication indicated for the management of type 2 diabetes. It is part of the class of drugs known as SGLT2 inhibitors, which are used to lower blood sugar levels in adults with diabetes.
Uses
GLIDAPAFLOZIN 5 is used to:
Improve blood sugar control in adults with type 2 diabetes mellitus.
Reduce the risk of cardiovascular events in diabetic patients with established heart disease.
Potentially aid in weight loss and blood pressure reduction as secondary effects.
Mechanism of Action
GLIDAPAFLOZIN 5 works by inhibiting sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to the excretion of excess glucose through the urine. This process helps to lower blood glucose levels without relying on insulin.
Dosage
Initial Dosage: The recommended starting dose for GLIDAPAFLOZIN 5 is 5 mg, taken once daily in the morning, with or without food.
Maintenance Dosage: Based on efficacy and tolerability, the dose may be adjusted under the guidance of a healthcare provider.
Administration: The tablet should be swallowed whole and not split, chewed, or crushed.
Side Effects
Common side effects associated with GLIDAPAFLOZIN 5 include:
Urinary tract infections and genital infections.
Increased urination.
Dizziness or lightheadedness, especially upon standing.
Dehydration and related symptoms such as dry mouth, thirst, or weakness.
More serious side effects might include diabetic ketoacidosis, kidney problems, and severe urinary tract infections. Patients should seek immediate medical attention if they experience significant side effects.
Interactions
GLIDAPAFLOZIN 5 can interact with other medications, which may alter its effectiveness or increase side effects. Notable interactions include:
Diuretics (increase the risk of dehydration)
Insulin and other insulin-stimulating drugs (increase the risk of hypoglycemia)
Certain antifungal and antibiotic medications
Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements.
Precautions
Renal Function: Patients with impaired kidney function may not be suitable candidates for GLIDAPAFLOZIN 5 due to increased risk of side effects.
Alcohol Use: Alcohol can increase the risk of hypoglycemia and dehydration with GLIDAPAFLOZIN 5. Conclusion
GLIDAPAFLOZIN 5 is an effective treatment option for improving blood sugar control in adults with type 2 diabetes. It is important for patients to work closely with their healthcare provider to monitor their condition and adjust the treatment as necessary.
Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.
For further information:
EMAIL: info@sterispharma.com / contact@sterispharma.com
CALL/WHATSAPP: 7877551268, 7849827488
 GLIDAPAFLOZIN 5 is a)
Submit Your Enquiry